Skip to main content
. 2017 May 16;20(Suppl 3):21577. doi: 10.7448/IAS.20.4.21577

Table 2.

Key outcomes in paediatric and adult care (n = 271)

  Paediatric care
Adult care
 
  n (%) /median [IQR] p value
Prescribed ART at last follow-up 200 (74%) 228 (84%) 0.001
CD4 count 12 months pre/post transfer (n = 204*) 465 [288,668] 460 [290,670] 0.38
CD4 < 200 cells/mm3 at least once in 12 months pre/post transfer (n = 195*) 41 (21%) 45 (23%) 0.39
Two consecutive VL >400 copies/mL or one VL>10,000 copies/mL in 12 months pre/post transfer for those on ART for at least 6 months (n = 131*) 37 (28%) 38 (29%) 0.85
Two consecutive VL >400 copies/mL or one VL>10,000 copies/mL in 12 months pre/post transfer irrespective of ART status (n = 196*) 92 (47%) 102 (52%) 0.12

IQR, interquartile range; ART, antiretroviral therapy*n = number with paediatric and adult care data.